← FDA Drug Approvals (Drugs@FDA)

IYUZEH

NDA · New Drug Application · Sponsor: THEA PHARMA · Approved 2022-12-13

Drug application

FDA Application #

NDA216472

Application type

New Drug Application

Brand name

IYUZEH

Generic name

LATANOPROST OPHTHALMIC SOLUTION 0.005%

Active ingredients

LATANOPROST

Dosage form

SOLUTION/DROPS

Route

OPHTHALMIC

Marketing status

Prescription

Sponsor

THEA PHARMA

Manufacturer

Thea Pharma Inc.

First approval

2022-12-13

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown